{"transactions":[{"id":3346363,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":153219,"kind":"person","name":"Londei Marco","position":1,"cik":"0001654500","reported_name":"Londei Marco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-12-10T22:38:41.000Z","date":"2019-12-06","kind":"grant","acquired":true,"shares":98000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to 25% of the shares subject to the option on December 6, 2020, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date."}],"balance_after":98000,"derivative":{"exercise_price":14.02,"expiration_date":"2029-12-05","underlying":"Common Stock","underlying_shares":98000},"source":{"system":"sec-edgar","filing":"0001209191-19-059923","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919119059923/doc4.xml","form_type":"4"}},{"id":3355678,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":153219,"kind":"person","name":"Londei Marco","position":1,"cik":"0001654500","reported_name":"Londei Marco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-12-02T21:29:04.000Z","date":"2019-11-27","kind":"exercise","acquired":false,"shares":46202,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option is fully vested and immediately exercisable."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In addition to the remaining options to purchase 4,946 shares of common stock as set forth in Table II, the Reporting Person also holds (i) additional options to purchase up to an aggregate of 173,000 shares of common stock, which options vest according to their terms, and (ii) 68,579 shares of common stock held directly."}],"balance_after":4946,"derivative":{"exercise_price":6.93,"expiration_date":"2025-08-13","underlying":"Common Stock","underlying_shares":46202},"source":{"system":"sec-edgar","filing":"0001209191-19-058549","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919119058549/doc4.xml","form_type":"4"}},{"id":3355677,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":153219,"kind":"person","name":"Londei Marco","position":1,"cik":"0001654500","reported_name":"Londei Marco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-12-02T21:29:04.000Z","date":"2019-11-27","kind":"exercise","acquired":true,"shares":46202,"price":6.93,"value":320179.86,"ownership":{"direct":true},"balance_after":68579,"source":{"system":"sec-edgar","filing":"0001209191-19-058549","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919119058549/doc4.xml","form_type":"4"}},{"id":3500093,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":153219,"kind":"person","name":"Londei Marco","position":1,"cik":"0001654500","reported_name":"Londei Marco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-06-05T21:54:18.000Z","date":"2019-06-04","kind":"exercise","acquired":false,"shares":10060,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option vested and became exercisable as to 25% of the shares subject to the option on October 24, 2015, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"The Reporting Person also holds (i) additional options to purchase up to an aggregate of 224,148 shares of common stock, which options vest according to their terms, and (ii) 22,377 shares of common stock held directly."}],"balance_after":0,"derivative":{"exercise_price":0.7,"expiration_date":"2024-10-27","underlying":"Common Stock","underlying_shares":10060},"source":{"system":"sec-edgar","filing":"0001209191-19-034870","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919119034870/doc4.xml","form_type":"4"}},{"id":3500092,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":153219,"kind":"person","name":"Londei Marco","position":1,"cik":"0001654500","reported_name":"Londei Marco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-06-05T21:54:18.000Z","date":"2019-06-04","kind":"sale","acquired":false,"shares":2003,"price":74.4978,"value":149219.0934,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.085 to $74.78 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":22377,"source":{"system":"sec-edgar","filing":"0001209191-19-034870","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919119034870/doc4.xml","form_type":"4"}},{"id":3500091,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":153219,"kind":"person","name":"Londei Marco","position":1,"cik":"0001654500","reported_name":"Londei Marco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-06-05T21:54:18.000Z","date":"2019-06-04","kind":"sale","acquired":false,"shares":2048,"price":73.4296,"value":150383.8208,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.04 to $73.98 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":24380,"source":{"system":"sec-edgar","filing":"0001209191-19-034870","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919119034870/doc4.xml","form_type":"4"}},{"id":3500090,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":153219,"kind":"person","name":"Londei Marco","position":1,"cik":"0001654500","reported_name":"Londei Marco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-06-05T21:54:18.000Z","date":"2019-06-04","kind":"sale","acquired":false,"shares":6009,"price":72.4511,"value":435358.6599,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.00 to $72.99 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":26428,"source":{"system":"sec-edgar","filing":"0001209191-19-034870","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919119034870/doc4.xml","form_type":"4"}},{"id":3500089,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":153219,"kind":"person","name":"Londei Marco","position":1,"cik":"0001654500","reported_name":"Londei Marco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-06-05T21:54:18.000Z","date":"2019-06-04","kind":"exercise","acquired":true,"shares":10060,"price":0.7,"value":7042.0,"ownership":{"direct":true},"balance_after":32437,"source":{"system":"sec-edgar","filing":"0001209191-19-034870","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919119034870/doc4.xml","form_type":"4"}},{"id":3665489,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":153219,"kind":"person","name":"Londei Marco","position":1,"cik":"0001654500","reported_name":"Londei Marco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-02-11T22:28:42.000Z","date":"2019-02-08","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to 25% of the shares subject to the option on February 8, 2020, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date."}],"balance_after":35000,"derivative":{"exercise_price":68.89,"expiration_date":"2029-02-07","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001209191-19-009024","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919119009024/doc4.xml","form_type":"4"}},{"id":3694400,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":153219,"kind":"person","name":"Londei Marco","position":1,"cik":"0001654500","reported_name":"Londei Marco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-01-17T00:09:37.000Z","date":"2019-01-15","kind":"exercise","acquired":false,"shares":19075,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option vested and became exercisable as to 25% of the shares subject to the option on August 13, 2016, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"In addition to the remaining options to purchase 51,148 shares of common stock as set forth in Table II above, the Reporting Person also holds (i) additional options to purchase up to an aggregate of 148,060 shares of common stock, which options vest according to their terms, and (ii) 22,377 shares of common stock held directly."}],"balance_after":51148,"derivative":{"exercise_price":6.93,"expiration_date":"2025-08-13","underlying":"Common Stock","underlying_shares":19075},"source":{"system":"sec-edgar","filing":"0001209191-19-003996","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919119003996/doc4.xml","form_type":"4"}},{"id":3694399,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":153219,"kind":"person","name":"Londei Marco","position":1,"cik":"0001654500","reported_name":"Londei Marco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-01-17T00:09:37.000Z","date":"2019-01-15","kind":"sale","acquired":false,"shares":14894,"price":70.0413,"value":1043195.1222,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.63 to $70.37 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":22377,"source":{"system":"sec-edgar","filing":"0001209191-19-003996","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919119003996/doc4.xml","form_type":"4"}},{"id":3694398,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":153219,"kind":"person","name":"Londei Marco","position":1,"cik":"0001654500","reported_name":"Londei Marco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-01-17T00:09:37.000Z","date":"2019-01-15","kind":"sale","acquired":false,"shares":4181,"price":69.2864,"value":289686.4384,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.63 to $69.60 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":37271,"source":{"system":"sec-edgar","filing":"0001209191-19-003996","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919119003996/doc4.xml","form_type":"4"}},{"id":3694397,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":153219,"kind":"person","name":"Londei Marco","position":1,"cik":"0001654500","reported_name":"Londei Marco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-01-17T00:09:37.000Z","date":"2019-01-15","kind":"exercise","acquired":true,"shares":19075,"price":6.93,"value":132189.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."}],"balance_after":41452,"source":{"system":"sec-edgar","filing":"0001209191-19-003996","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919119003996/doc4.xml","form_type":"4"}},{"id":3694396,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":153219,"kind":"person","name":"Londei Marco","position":1,"cik":"0001654500","reported_name":"Londei Marco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-01-17T00:09:37.000Z","date":"2018-12-26","kind":"gift","acquired":false,"shares":122500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Issuer's common stock that were donated as a charitable contribution. The reporting person does not exercise voting or dispositive powers, directly or indirectly, over the donated shares following this transfer."}],"balance_after":22377,"source":{"system":"sec-edgar","filing":"0001209191-19-003996","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919119003996/doc4.xml","form_type":"4"}},{"id":3726388,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":153219,"kind":"person","name":"Londei Marco","position":1,"cik":"0001654500","reported_name":"Londei Marco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-12-19T02:48:48.000Z","date":"2018-12-17","kind":"exercise","acquired":false,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The stock option vested and became exercisable as to 25% of the shares subject to the option on August 13, 2016, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F8","text":"In addition to the remaining options to purchase 80,283 shares of common stock as set forth in Table II, the Reporting Person also holds (i) 144,877 shares of common stock held directly; and (ii) additional options to purchase up to an aggregate of 138,000 shares of common stock, which options vest according to their terms."}],"balance_after":70223,"derivative":{"exercise_price":6.93,"expiration_date":"2025-08-13","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001209191-18-063384","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919118063384/doc4.xml","form_type":"4"}},{"id":3726387,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":153219,"kind":"person","name":"Londei Marco","position":1,"cik":"0001654500","reported_name":"Londei Marco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-12-19T02:48:48.000Z","date":"2018-12-17","kind":"exercise","acquired":false,"shares":8048,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The stock option vested and became exercisable as to 25% of the shares subject to the option on October 24, 2015, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date."}],"balance_after":10060,"derivative":{"exercise_price":0.7,"expiration_date":"2024-10-27","underlying":"Common Stock","underlying_shares":8048},"source":{"system":"sec-edgar","filing":"0001209191-18-063384","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919118063384/doc4.xml","form_type":"4"}},{"id":3726386,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":153219,"kind":"person","name":"Londei Marco","position":1,"cik":"0001654500","reported_name":"Londei Marco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-12-19T02:48:48.000Z","date":"2018-12-17","kind":"sale","acquired":false,"shares":6741,"price":68.4732,"value":461577.8412,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.05 to $68.73 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":144877,"source":{"system":"sec-edgar","filing":"0001209191-18-063384","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919118063384/doc4.xml","form_type":"4"}},{"id":3726385,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":153219,"kind":"person","name":"Londei Marco","position":1,"cik":"0001654500","reported_name":"Londei Marco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-12-19T02:48:48.000Z","date":"2018-12-17","kind":"sale","acquired":false,"shares":8002,"price":67.5686,"value":540683.9372,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.02 to $68.01 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":151618,"source":{"system":"sec-edgar","filing":"0001209191-18-063384","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919118063384/doc4.xml","form_type":"4"}},{"id":3726384,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":153219,"kind":"person","name":"Londei Marco","position":1,"cik":"0001654500","reported_name":"Londei Marco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-12-19T02:48:48.000Z","date":"2018-12-17","kind":"sale","acquired":false,"shares":3185,"price":66.3787,"value":211416.1595,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.00 to $66.92 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":159620,"source":{"system":"sec-edgar","filing":"0001209191-18-063384","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919118063384/doc4.xml","form_type":"4"}},{"id":3726383,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":153219,"kind":"person","name":"Londei Marco","position":1,"cik":"0001654500","reported_name":"Londei Marco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-12-19T02:48:48.000Z","date":"2018-12-17","kind":"sale","acquired":false,"shares":12120,"price":65.3612,"value":792177.744,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.00 to $65.99 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":162805,"source":{"system":"sec-edgar","filing":"0001209191-18-063384","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919118063384/doc4.xml","form_type":"4"}},{"id":3726382,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":153219,"kind":"person","name":"Londei Marco","position":1,"cik":"0001654500","reported_name":"Londei Marco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-12-19T02:48:48.000Z","date":"2018-12-17","kind":"exercise","acquired":true,"shares":22000,"price":6.93,"value":152460.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."}],"balance_after":174925,"source":{"system":"sec-edgar","filing":"0001209191-18-063384","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919118063384/doc4.xml","form_type":"4"}},{"id":3726381,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":153219,"kind":"person","name":"Londei Marco","position":1,"cik":"0001654500","reported_name":"Londei Marco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-12-19T02:48:48.000Z","date":"2018-12-17","kind":"exercise","acquired":true,"shares":8048,"price":0.7,"value":5633.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."}],"balance_after":152925,"source":{"system":"sec-edgar","filing":"0001209191-18-063384","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919118063384/doc4.xml","form_type":"4"}},{"id":3820408,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":153219,"kind":"person","name":"Londei Marco","position":1,"cik":"0001654500","reported_name":"Londei Marco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-09-10T23:06:06.000Z","date":"2018-09-07","kind":"exercise","acquired":false,"shares":142857,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vested and became exercisable as to 25% of the shares subject to the option on October 24, 2015, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date."}],"balance_after":18108,"derivative":{"exercise_price":0.7,"expiration_date":"2024-10-27","underlying":"Common Stock","underlying_shares":142857},"source":{"system":"sec-edgar","filing":"0001209191-18-050362","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919118050362/doc4.xml","form_type":"4"}},{"id":3820407,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":153219,"kind":"person","name":"Londei Marco","position":1,"cik":"0001654500","reported_name":"Londei Marco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-09-10T23:06:06.000Z","date":"2018-09-07","kind":"exercise","acquired":true,"shares":142857,"price":0.7,"value":99999.9,"ownership":{"direct":true},"balance_after":144877,"source":{"system":"sec-edgar","filing":"0001209191-18-050362","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919118050362/doc4.xml","form_type":"4"}},{"id":4084660,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":153219,"kind":"person","name":"Londei Marco","position":1,"cik":"0001654500","reported_name":"Londei Marco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-01-30T21:13:51.000Z","date":"2018-01-26","kind":"grant","acquired":true,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to 25% of the shares subject to the option on January 26, 2019, and thereafter vests as to\n1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the\nReporting Person on each vesting date."}],"balance_after":28000,"derivative":{"exercise_price":106.84,"expiration_date":"2028-01-25","underlying":"Common Stock","underlying_shares":28000},"source":{"system":"sec-edgar","filing":"0001209191-18-005997","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919118005997/doc4.xml","form_type":"4"}},{"id":4417011,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":153219,"kind":"person","name":"Londei Marco","position":1,"cik":"0001654500","reported_name":"Londei Marco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-02-28T23:42:25.000Z","date":"2017-02-24","kind":"grant","acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to 25% of the shares subject to the option on February 24, 2018, and thereafter vests as to\n1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the\nReporting Person on each vesting date."}],"balance_after":110000,"derivative":{"exercise_price":24.6,"expiration_date":"2027-02-23","underlying":"Common Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001209191-17-015444","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919117015444/doc4.xml","form_type":"4"}},{"id":4475029,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":153219,"kind":"person","name":"Londei Marco","position":1,"cik":"0001654500","reported_name":"Londei Marco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Series D Preferred Stock","published_at":"2017-01-31T21:47:38.000Z","date":"2017-01-31","kind":"exercise","acquired":false,"shares":2020,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"In connection with the consummation of the Issuer's initial public offering on January 31, 2017, each share of Series D Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration, and had no expiration date. All shares of Common Stock issued upon conversion were aggregated."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In connection with the consummation of the Issuer's initial public offering on January 31, 2017, each share of Series D Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration, and had no expiration date. All shares of Common Stock issued upon conversion were aggregated."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"In connection with the consummation of the Issuer's initial public offering on January 31, 2017, each share of Series D Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration, and had no expiration date. All shares of Common Stock issued upon conversion were aggregated."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":2020},"source":{"system":"sec-edgar","filing":"0001209191-17-006403","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919117006403/doc4.xml","form_type":"4"}},{"id":4475028,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":153219,"kind":"person","name":"Londei Marco","position":1,"cik":"0001654500","reported_name":"Londei Marco","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-01-31T21:47:38.000Z","date":"2017-01-31","kind":"exercise","acquired":true,"shares":2020,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the consummation of the Issuer's initial public offering on January 31, 2017, each share of Series D Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration, and had no expiration date. All shares of Common Stock issued upon conversion were aggregated."}],"balance_after":2020,"source":{"system":"sec-edgar","filing":"0001209191-17-006403","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919117006403/doc4.xml","form_type":"4"}}]}